Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
Clinical trial NCT01748877 · COMPLETED
Trial details
- NCT number
- NCT01748877
- Sponsor
- NeurAxon Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-06-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.